Soligenix Inc.
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. It operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a photodynamic therapy, which has completed Phase 3 clinical trial for the tre… Read more
Soligenix Inc. (SNGX) - Total Assets
Latest total assets as of September 2025: $11.29 Million USD
Based on the latest financial reports, Soligenix Inc. (SNGX) holds total assets worth $11.29 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Soligenix Inc. - Total Assets Trend (1995–2024)
This chart illustrates how Soligenix Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Soligenix Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Soligenix Inc.'s total assets of $11.29 Million consist of 98.5% current assets and 1.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 87.2% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1995–2024)
This chart illustrates how Soligenix Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Soligenix Inc.'s current assets represent 98.5% of total assets in 2024, an increase from 74.3% in 1995.
- Cash Position: Cash and equivalents constituted 87.2% of total assets in 2024, up from 71.2% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 12.0% in 1995.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Soligenix Inc. Competitors by Total Assets
Key competitors of Soligenix Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Soligenix Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Soligenix Inc. generates 0.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Soligenix Inc. is currently not profitable relative to its asset base.
Soligenix Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.18 | 2.28 | 3.20 |
| Quick Ratio | 3.18 | 2.28 | 3.20 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $7.46 Million | $ 5.78 Million | $ 13.39 Million |
Soligenix Inc. - Advanced Valuation Insights
This section examines the relationship between Soligenix Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.57 |
| Latest Market Cap to Assets Ratio | 1.34 |
| Asset Growth Rate (YoY) | -8.5% |
| Total Assets | $8.97 Million |
| Market Capitalization | $12.00 Million USD |
Valuation Analysis
Above Book Valuation: The market values Soligenix Inc.'s assets above their book value (1.34 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Soligenix Inc.'s assets decreased by 8.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Soligenix Inc. (1995–2024)
The table below shows the annual total assets of Soligenix Inc. from 1995 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $8.97 Million | -8.48% |
| 2023-12-31 | $9.80 Million | -31.39% |
| 2022-12-31 | $14.28 Million | -46.86% |
| 2021-12-31 | $26.87 Million | +35.08% |
| 2020-12-31 | $19.89 Million | +155.82% |
| 2019-12-31 | $7.78 Million | -25.89% |
| 2018-12-31 | $10.49 Million | +9.86% |
| 2017-12-31 | $9.55 Million | -6.99% |
| 2016-12-31 | $10.27 Million | +38.99% |
| 2015-12-31 | $7.39 Million | +6.22% |
| 2014-12-31 | $6.95 Million | -15.86% |
| 2013-12-31 | $8.27 Million | +75.67% |
| 2012-12-31 | $4.71 Million | -42.79% |
| 2011-12-31 | $8.22 Million | -11.27% |
| 2010-12-31 | $9.27 Million | -1.23% |
| 2009-12-31 | $9.38 Million | +179.07% |
| 2008-12-31 | $3.36 Million | -11.13% |
| 2007-12-31 | $3.78 Million | +168.94% |
| 2006-12-31 | $1.41 Million | -58.28% |
| 2005-12-31 | $3.37 Million | -33.45% |
| 2004-12-31 | $5.07 Million | -18.94% |
| 2003-12-31 | $6.25 Million | +7.09% |
| 2002-12-31 | $5.84 Million | -47.13% |
| 2001-12-31 | $11.04 Million | -19.22% |
| 2000-12-31 | $13.67 Million | +47.43% |
| 1999-12-31 | $9.27 Million | -42.76% |
| 1998-12-31 | $16.20 Million | -15.18% |
| 1997-12-31 | $19.10 Million | +1428.00% |
| 1996-12-31 | $1.25 Million | -12.93% |
| 1995-12-31 | $1.44 Million | -- |